Lessons from research on perceptions of COVID-19 vaccination for pregnant women in Côte d’Ivoire – January 2023
Although the population of Côte d’Ivoire has reached 58% of the vaccination target, there is still work to be done to encourage people with doubts to get vaccinated. The government of Côte d’Ivoire has authorized the Pfizer vaccine for pregnant women since January 2023 (Circular 00103/2023). Breakthrough ACTION supports the government of Côte d’Ivoire through social and behavior change (SBC) interventions, including research and monitoring to inform COVID-19 vaccination activities. The Breakthrough ACTION team, in partnership with the Department of Health and USAID, collected qualitative data from three sites to assess concern about COVID-19, perceptions of the current vaccine rollout, standards perceptions around vaccination, how misinformation and other factors influence vaccine uptake. This analysis focuses on a subset of data relating to perceptions of COVID-19 among pregnant women.
- Caroline Jacoby
- cjacoby@jhu.edu
Views 791
